Holen Sie sich die Stockscreener-App
3.01
1.31%
-0.04
Ac Immune Sa Aktie (ACIU) Neueste Nachrichten
ACIU Reiterated by BTIG -- Price Target Maintained at $8.00 - GuruFocus
MSN Money - MSN
AC Immune Releases Q1 2026 Financial Results - AlphaStreet
ACIU Reports Strong Q1 Revenue Growth and Advances Neurodegenera - GuruFocus
AC Immune reports Q1 EPS (15c), consensus (14c) - TipRanks
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline - TipRanks
AC Immune doses first patient in final ABATE trial cohort By Investing.com - Investing.com South Africa
AC Immune doses first patient in final ABATE trial cohort - Investing.com
AC Immune First Quarter 2026 Financial and Corporate Updates - The Manila Times
AC Immune: Q1 Earnings Snapshot - Barchart.com
AC Immune (NASDAQ: ACIU) trims Q1 2026 loss, sees cash runway into Q4 2027 - Stock Titan
AC Immune (NASDAQ: ACIU) triggers $12M Takeda milestone with final ABATE cohort - Stock Titan
AC Immune lines up 3 brain-disease trial readouts for 2026 - Stock Titan
$12M milestone as AC Immune adds final Alzheimer's trial cohort - Stock Titan
AC Immune SA (HAM:IMR) Dividend - GuruFocus
AC Immune SA (HAM:IMR) Stock Price & 30 Year Financial Data - GuruFocus
Who's Buying or Selling AC Immune SA (HAM:IMR) Stock Today? - GuruFocus
AC Immune SA Stock Baskets - GuruFocus
AC Immune Stock Operating Data - GuruFocus
AC Immune SA (HAM:IMR) Stock Earnings Transcripts - GuruFocus
AC Immune SA (HAM:IMR) Stock Price, Trades & News - GuruFocus
AC Immune SA (HAM:IMR) Stock News, Headlines & Updates - GuruFocus
AC Immune SA (HAM:IMR) Stock HoldersInstitutional & Insider Ownership - GuruFocus
AC Immune SA (HAM:IMR) Competitors 2026 - GuruFocus
AC Immune SA (HAM:IMR)Valuation Measures & Financial Statistics - GuruFocus
ACIU stock rallies 16.3% in a week: Here's what you need to know - MSN
ACIU.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
ACIU.O Technical Analysis & Stock Price Forecast - Intellectia AI
AC Immune revises collaboration with Eli Lilly on tau-targeting Alzheimer’s therapy - MSN
ACIU Should I Buy - Intellectia AI
ACIU.O Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ACIU.O PE Ratio & Valuation, Is ACIU.O Overvalued - Intellectia AI
ACIU.O Forecast — Price Prediction for 2026. Should I Buy ACIU.O? - Intellectia AI
Martin Zuegel Net Worth (2026) - GuruFocus
Renee Aguiar Lucander Net Worth (2026) - GuruFocus
Carl Howard June Net Worth (2026) - GuruFocus
Monika Buetler Net Worth (2026) - GuruFocus
Top Executive Makes Notable Move With Fresh AC Immune Stock Sale - TipRanks
Roy Ervin Twyman Net Worth (2026) - GuruFocus
Christopher James Roberts Net Worth (2026) - GuruFocus
Piergiorgio Donati Net Worth (2026) - GuruFocus
Insider Stock Purchases: April 16, 2026 - Moomoo
AC Immune (ACIU) CEO Pfeifer logs 10,000-share sale in amended Form 4 - Stock Titan
AC Immune (ACIU) CEO adds 10,000 shares in open-market buy - Stock Titan
Andrea Pfeifer (NASDAQ: ACIU) plans sale of 10,000 shares under Form 144 - Stock Titan
AC Immune secures CHF 10 million from Lilly to advance Alzheimer’s therapy - Greater Geneva Bern area
Leerink Says AC Immune (ACIU) Eli Lilly Tau Program Amendment Is Great News - Insider Monkey
0.14%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):